Overview
Overview
An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya
Principal Investigator
Principle Instigator
Prof Walter Jaoko
Abstract
Abstract
Primary Objective: To measure cervical mucosal immune activation after VZV vaccination in the context of VZV-effector responses.
